Statement of Changes in Beneficial Ownership (4)
December 08 2017 - 5:27PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
WHITE MILES D
|
2. Issuer Name
and
Ticker or Trading Symbol
ABBOTT LABORATORIES
[
ABT
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
Chairman and CEO
|
(Last)
(First)
(Middle)
100 ABBOTT PARK ROAD
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
12/6/2017
|
(Street)
ABBOTT PARK, IL 60064-6400
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common shares without par value
|
12/6/2017
|
|
M
|
|
530000
|
A
|
$26.6973
|
3677913
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
600
|
D
|
$54.325
|
3677313
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
2800
|
D
|
$54.33
|
3674513
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
1000
|
D
|
$54.34
|
3673513
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
300
|
D
|
$54.345
|
3673213
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
800
|
D
|
$54.35
|
3672413
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
2650
|
D
|
$54.355
|
3669763
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
7450
|
D
|
$54.36
|
3662313
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
2407
|
D
|
$54.365
|
3659906
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
8035
|
D
|
$54.37
|
3651871
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
5199
|
D
|
$54.375
|
3646672
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
16446
|
D
|
$54.38
|
3630226
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
8502
|
D
|
$54.385
|
3621724
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
27636
|
D
|
$54.39
|
3594088
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
5435
|
D
|
$54.395
|
3588653
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
100
|
D
|
$54.3975
|
3588553
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
19900
|
D
|
$54.40
|
3568653
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
14181
|
D
|
$54.405
|
3554472
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
100
|
D
|
$54.4075
|
3554372
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
24651
|
D
|
$54.41
|
3529721
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
8167
|
D
|
$54.415
|
3521554
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
100
|
D
|
$54.4175
|
3521454
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
39699
|
D
|
$54.42
|
3481755
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
21402
|
D
|
$54.425
|
3460353
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
19665
|
D
|
$54.43
|
3440688
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
10833
|
D
|
$54.435
|
3429855
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
9150
|
D
|
$54.44
|
3420705
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
3501
|
D
|
$54.445
|
3417204
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
13800
|
D
|
$54.45
|
3403404
|
D
|
|
Common shares without par value
|
12/6/2017
|
|
S
|
|
2377
|
D
|
$54.455
|
3401027
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Option (right to buy)
(1)
|
$26.6973
|
12/6/2017
|
|
M
|
|
|
530000
|
2/15/2011
|
2/14/2018
|
Common shares
|
530000
|
$0
|
0
|
D
|
|
Explanation of Responses:
|
(1)
|
Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
|
Remarks:
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Form 1 of 5.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
WHITE MILES D
100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064-6400
|
X
|
|
Chairman and CEO
|
|
Signatures
|
John A. Berry, by power of attorney for Miles D. White
|
|
12/8/2017
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Apr 2023 to Apr 2024